2015 | T 2 - and T*2-weighted MRI of rat glioma using polysorbate-coated magnetic nanocrystals as a blood-pool contrast agent | RSC ADVANCES |
2019 | Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases | JOURNAL OF NEURO-ONCOLOGY |
2013 | Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
| JOURNAL OF KOREAN NEUROSURGICAL SOCIETY |
2016 | Terahertz reflectometry imaging for low and high grade gliomas
| SCIENTIFIC REPORTS |
2015 | The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival | AMERICAN JOURNAL OF NEURORADIOLOGY |
2017 | The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter | AMERICAN JOURNAL OF NEURORADIOLOGY |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
| Brain Tumor Research and Treatment |
2023 | The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.3)
| Brain Tumor Research and Treatment |
2023 | The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Survey About Specific Clinical Scenarios (Version 2023.1)
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2018 | The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model
| SCIENTIFIC REPORTS |
2022 | Tissue Niche Miniature of Glioblastoma Patient Treated with Nano-Awakeners to Induce Suicide of Cancer Stem Cells | ADVANCED HEALTHCARE MATERIALS |
2019 | Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
| Scientific Reports |
2020 | Ttreatment results for recurrent glioblastoma and alteration of PD-L1 expression after recurrence | WORLD NEUROSURGERY |
2016 | Tumor mesenchymal stem-like cell as a prognostic marker in primary glioblastoma
| STEM CELLS INTERNATIONAL |
2017 | Tumor-associated mesenchymal stem-like cells provide extracellular signaling cue for invasiveness of glioblastoma cells
| ONCOTARGET |
2022 | Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |
2020 | Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma | STRAHLENTHERAPIE UND ONKOLOGIE |
2024 | Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment | NEURO-ONCOLOGY |
2018 | Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas | AMERICAN JOURNAL OF NEURORADIOLOGY |